Virtual screening of approved drugs against purine nucleoside phosphorylase of Schistosoma mansoni

Rama, M and Kumar, Anil N V and Balaji, S (2015) Virtual screening of approved drugs against purine nucleoside phosphorylase of Schistosoma mansoni. International Journal of Computational Biology and Drug Design, 8 (4). pp. 383-400. ISSN 1756-0756

[img] PDF
540.pdf - Published Version
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract

Schistosomiasis is an endemic neglected tropical disease caused by trematodes of the genus Schistosoma. Purine nucleoside phosphorylase (PNP) of purine salvage pathway is essential for recovery of nucleosides in Schistosoma species. Schistosoma mansoni PNP (SmPNP) is well-explored drug target for schistosomiasis. The currently available drugs have adverse effects such as abdominal discomfort, nausea, drowsiness and pyrexia. Hence, there is a need for new compounds exhibiting anti-schistosomal activity with minimal or no side effects. In the present study, virtual screening of approved drugs from Drug Bank was compared against Schistosoma mansoni and human PNPs. Among the approved drugs, 15 molecules were selected based on the interaction scores, out of which 11 drugs interacted with SmPNP and the remaining four interacted with human PNP.

Item Type: Article
Uncontrolled Keywords: schistosomiasis; Schistosoma mansoni; PNP; purine nucleoside phosphorylase; anti-schistosomal agents; drug repurposing
Subjects: Engineering > MIT Manipal > Biotechnology
Engineering > MIT Manipal > Chemistry
Depositing User: MIT Library
Date Deposited: 10 May 2016 13:37
Last Modified: 10 May 2016 13:37
URI: http://eprints.manipal.edu/id/eprint/146004

Actions (login required)

View Item View Item